Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Trial compares 1% Terbinafine vs 1% Clotrimazole C...
A randomized controlled trial showed that for Tinea pedis (athletic foot) management, 1 week Terbinafine twice a day is as effective as 4 weeks C...
3 min
Tirzepatide injection gets FDA approval for chroni...
According to the notification published on 8 Nov 2023, the United States Food and Drug Administration (US-FDA) has authorized Tirzepatide injecti...
4 min
Study reveals the effect of Isotretinoin on menstr...
Novel findings from a recent prospective observational study shed light on the impact of oral intake of Isotretinoin on menstrual cycles among ac...
1 min
Study assesses efficacy of ketorolac for treatment...
In people presenting with migraine headache, ketorolac might have similar effectiveness when compared to phenothiazines and metoclopramide for mi...
3 min
Is alcohol safe for rheumatoid arthritis patients...
Rheumatoid Arthritis (RA) patients taking Methotrexate (MTX) are often advised to decrease their alcohol intake due to the increased risk of hepa...
2 min
Understanding bleeding patterns associated with ea...
A recent study published in the Maternal-Fetal Medicine Journal found that terminated bleeding after 2 weeks is a predictive indicator for effe...
2 min
Paracetamol vs Ibuprofen. Which is better for trea...
In a systematic review and meta-analysis, both Paracetamol and Ibuprofen demonstrated superior effectiveness compared to a placebo in addressing...
3 min
Does exercise induce GERD or relieve acid reflux?...
Different factors are accountable for the impact of exercise or physical activity on the onset of gastroesophageal reflux disease (GERD), a sessi...
3 min
GERD Symptoms: Could Intermittent Fasting Help?
A study published in the "Journal of Clinical Gastroenterology" showed symptomatic relief in gastroesophageal reflux disease (GERD) sym...
2 min
Clinical features of a headache or facial pain bef...
Herpes zoster (HZ) also known as shingles is a painful, blistering skin eruption in a dermatomal distribution. When the patients are suffering fr...
3 min
Tegoprazan matches PPI healing rates in erosive esophagitis
Tegoprazan redefines treatment for erosive esophagitis, delivering results on par with PPIs while drawing focus to the evaluation of its long-ter...
GLP-1 therapies show strongest preoperative weight loss benefits...
Preoperative GLP-1 therapy delivers the greatest weight reduction in patients with severe obesity, optimizing surgical outcomes and redefining st...
Which hidden barriers prevent effective treatment adherence in CS...
Multiple social, therapeutic, and healthcare-related factors contribute to poor treatment adherence in CSU, highlighting the need for patient-cen...
Real-world data raise concerns over PPI safety in infants
A new FAERS analysis raises concern over the safety of PPIs in infants, showing that drugs like lansoprazole increase the risk of adverse events...
Ketorolac relieves pain during photodynamic therapy for genital w...
Ketorolac tromethamine + two-step irradiation significantly reduces pain and boosts patient satisfaction during ALA-PDT for condyloma acuminatum....
Global analysis reveals modern lifestyle factors behind AD epidem...
Global atopic dermatitis incidence rises with socioeconomic development and is positively associated with obesity, air pollution, physical inacti...
FDA expands access to omalizumab therapy with first interchangeab...
The FDA has authorized omalizumab-igec as the first interchangeable biosimilar to omalizumab for treating asthma, urticaria, chronic rhinosinusit...
FDA introduces front-of-package nutrition labels to tackle chroni...
The FDA has proposed requisition of front-of-package nutrition labels on most packaged foods to clearly display levels of saturated fat, sodium,...
EMA issues flu vaccine composition guidance for 2025/2026 season
EMA recommends updated trivalent influenza vaccines for the 2025/2026 season, selecting strains based on global surveillance data and excluding B...
Reddy’s and Henlius collaborate to commercialize daratumumab bios...
Dr. Reddy’s has secured exclusive U.S. and Europe commercialization rights for Henlius’s daratumumab biosimilar HLX15 in a deal worth...
Dr. Reddy’s and Bio-Thera forge strategic alliance to expand bios...
Dr. Reddy’s and Bio-Thera Solutions have entered into exclusive commercialization and license agreements for two proposed biosimilars&mdash...
Sanofi and Dr. Reddy’s partner to introduce RSV protection for pe...
Dr. Reddy’s Laboratories has entered into an exclusive agreement with Sanofi to promote and distribute nirsevimab in India—a single-d...
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.